S4 to 108 ncats gene therapy vector

Ended Awarded Last action

Contract number
75N98021F00357
Awardee
Awarding agency
Obligated
$6,298,050

Award facts

Contract value 70% obligated
  • $6,298,050.00 Current, with exercised options
  • $8,960,050.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00006 $0
Supplemental Agreement for work within scope P00005 $165,000
Exercise an Option P00004 $0
Supplemental Agreement for work within scope P00003 · National institutes of health (NIH), national center for advancing translational sciences (ncats), intramural research program (IRP), division of preclinical… $2,338,050
Supplemental Agreement for work within scope P00002 · Generation of national center for advancing translational sciences (ncats)-AAV9-mmab gene therapy vectors S4 to 108 ncats gene therapy vector $0
Supplemental Agreement for work within scope P00001 $0
Original award $3,795,000

About this award

Guidehouse Digital LLC received a delivery order valued at $8.96M under the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) for the development of NCATS-AAV9-MMAB gene therapy vector. The delivery order, awarded on September 24, 2021, with an ultimate completion date of September 29, 2026, is structured as a firm fixed-price contract with no set-aside designation. Work will be performed in Rockville, Maryland, supporting NCATS' Therapeutic Development Branch within the Division of Preclinical Innovation. This engagement aligns with NCATS' mission to advance translational science by developing innovative approaches and tools to speed the delivery of interventions for a wide range of diseases.

Gene therapy vectors, particularly adeno-associated viruses (AAVs), represent critical infrastructure for modern therapeutic development. This contract supports the preclinical innovation and therapeutic development capabilities within NCATS' Intramural Research Program, enabling the agency to generate and characterize specialized gene therapy vectors essential for advancing potential treatments. Guidehouse Digital LLC's extensive experience with biomedical research support, scientific computing, and laboratory management through multiple NIH contracts positions the firm to provide the technical and operational resources required for this specialized research initiative.

Quick answers

Who was awarded contract 75N98021F00357?

75N98021F00357 was awarded to Guidehouse Digital LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 24, 2021.

How much is contract 75N98021F00357 worth?

The government has obligated $6,298,050 on 75N98021F00357. Its potential value, with all options, is $8,960,050.

Is contract 75N98021F00357 an order under another contract?

Yes. 75N98021F00357 is a delivery order under 75N98020D00086, an indefinite delivery contract.

Was contract 75N98021F00357 competed?

The extent of competition for 75N98021F00357 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award